Safeguarding patients in clinical trials with high mortality rates

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 2, 2001, Pages 190-192

  Freeman, Bradley D ^a,b   Danner, Robert L ^a,b   Banks, Steven M ^a,b   Natanson, Charles ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; HUMAN GROWTH HORMONE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

BLOOD SUBSTITUTION; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; CRITICAL ILLNESS; DISEASE SEVERITY; DRUG EFFECT; DRUG INFUSION; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HEMORRHAGIC SHOCK; HUMAN; LENGTH OF STAY; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT RIGHT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEPTIC SHOCK; SHORT SURVEY; TOXICITY;

EID: 0035880156     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.2.2011028     Document Type: Short Survey

References (22)

1. Increased mortality associated with growth hormone treatment in critically ill adults
2. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock
3. Multi-center, randomized, placebo-controlled, double blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock
4. Critical-care studies: Redefining the rules
5. Rethink about growth-hormone therapy for critically ill patients
6. Growth hormone therapy in critically ill patients
7. Dose-dependent effect of diaspirin cross-linked hemoglobin on regional blood circulation of severely hemorrhaged rats
8. Diaspirin cross-linked hemoglobin (DCLHB): Phase I clinical safety assessment in normal healthy volunteers
9. Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients
10. Differential effects of L-NMMA in endotoxemic and normal dogs
11. Protective and pathological roles of nitric oxide in endotoxin shock
12. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors
13. The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine
14. Inhibition of nitric oxide synthesis in septic shock: How much is beneficial?
15. An open-label dose escalation study of the nitric oxide synthase inhibitor, N-methyl-L-arginine hydrochloride (546C88), in patients with septic shock
16. The nitric oxide synthase inhibitor 564C88 promotes the resolution of shock in patients with severe sepsis
17. Pharmacokinetics of the nitric oxide synthase inhibitor L-N-G-methylarginine hydrochloride in patients with septic shock
18. The agonising negative trend in monitoring of clinical trials
19. Postoperative nitrogen balance with intravenous hyponutrition and growth hormone
20. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: A double-blind, randomized controlled study
21. Increased survival after major thermal injuries: The effect of growth hormone therapy in adults